Who would want to do business with a company that is grossly overcharging consumers and insurance companies for Daraprim? I doubt that Vyera could find a lender.
Mulholland took himself out as CFO, he is staying with the company as senior Vice President, that’s not an exit to me. He decided to lighten his load but stay with the company, he hasn’t jumped ship or abandoned the company, I don’t get the fanatical hype at all.